Patent settlements reached by drug companies including Bayer AG may violate antitrust laws, a U.S. appeals court said, citing a rise in cases in which makers of brand-name medicines pay rivals to delay generic products...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Drug Patent Settlements May Be Illegal, Court Says (Update1)
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account